EGFR and non-small cell lung carcinoma: Dihydromyricetin suppressed EGFR signaling to inhibit survivin expression, resulting in the downregulation of survivin phosphorylation and the degradation of survivin induced by ubiquitination in non-small cell lung cancer cells 57.